2318 Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer. (September 2015) - Jung, K.S.; Song, H.N.; Yoo, K.H.; Cho, J.; Kim, S.T.; Lee, J.; Park, S.H.; Park, Y.S.; Lim, H.Y.; Kang, W.K.; Park, J.O.